When COVID-19 hit, the biotech sector became the primary focus of the entire stock market. Last year everybody was talking about the vaccine race, and some anonymous companies became household names. What will happen to biotech stocks in 2021? Corinne Cardina, bureau chief for Healthcare and Cannabis at Fool.com, and Motley Fool writer Taylor Carmichael discuss major trends in the biotech sector. This segment was recorded live on March 5. 

Corinne Cardina: What would you say are kind of the big themes for biotech that we saw in 2020, and what do you think are already emerging as the defining topics for 2021?

Taylor Carmichael: Yeah, 2020 obviously COVID-19 overwhelmed everything, and in your biotech portfolio, you really could tell the difference, if you had a COVID-19 fighter or you did not. We had incredible numbers from small cap companies that were providing vaccines or doing diagnostics. They had amazing growth last year. COVID-19 overwhelmed the entire stock market, not just biotechs, but that it was a huge difference because a lot of companies, they had to shut down clinical trials, there was just a massive shutdown. But the companies and there were quite a number of them actually that were focused on COVID-19 did really well. We're still seeing that in 2021. That's carried over into 2021 that in 2020 it was all anticipation about what the numbers would look like and whether they would get FDA approval. Now in 2021, we pretty much know the vaccines are going to be hitting the market. The diagnostic companies reporting amazing numbers, Fulgent(NASDAQ:FLGT) just came out yesterday with some amazing numbers, and the stock just skyrocketed. We're transitioning from anticipation of wonderful revenues to actual financials. It's mostly the small caps who really ridden a wave, I think, Moderna (NASDAQ:MRNA), Novavax(NASDAQ:NVAX), Fulgent, Co-Diagnostics (NASDAQ:CODX). It's really moving the needle, because they're tiny, and so much of COVID has taken over their business. That's still I think at least in my state, we're still in lockdown mode, so COVID-19 is still affecting the numbers. But I do think market looks ahead. It's a forward-looking mechanism and it's taking us out of COVID-19. Up till these last couple of weeks we've had a really good year. I guess, my number two for 2021 right now is we're having another crash that feels like a crash we had last year. I would not say that this is a COVID-related crash. It doesn't feel like that to me. Is just one of those kind of unexpected things that happen in the market, and that's where we've seen this week and last week. That's on our minds right now, I guess. But I don't think...this is not going to be a long term event in 2021. I do think we're going to come out of COVID this year. We're going to normalize, I think for Fools, you want to start thinking on the biotech side, how that process, how that shift is going to affect your different stocks.

More in category

Wells Fargo earnings jump as economy bounces back
April 14, 2021FOX Business
Wells Fargo earnings jump as economy bounces back
Stocks rise as Goldman, energy lead
April 14, 2021FOX Business
Stocks rise as Goldman, energy lead
3 Cannabis Stocks That Can Cash In on New York's Legal Pot Market David Jagielski | Apr 14, 2021
April 14, 2021The Motley Fool
3 Cannabis Stocks That Can Cash In on New York's Legal Pot Market David Jagielski | Apr 14, 2021
Got $1,000? 2 of Today's Hot Stocks You Can Buy and Hold for a Lifetime Rachel Warren | Apr 14, 2021
April 14, 2021The Motley Fool
Got $1,000? 2 of Today's Hot Stocks You Can Buy and Hold for a Lifetime Rachel Warren | Apr 14, 2021
These 3 Stocks Will Make You Rethink Your Portfolio Taylor Carmichael | Apr 14, 2021
April 14, 2021The Motley Fool
These 3 Stocks Will Make You Rethink Your Portfolio Taylor Carmichael | Apr 14, 2021
3 Bargain Stocks You Can Buy Right Now
April 14, 2021The Motley Fool
3 Bargain Stocks You Can Buy Right Now
Should You Buy These 3 Multibillion-Dollar Cathie Wood Investments?
April 14, 2021The Motley Fool
Should You Buy These 3 Multibillion-Dollar Cathie Wood Investments?
American Airlines sees bookings rebounding in summer
April 14, 2021Reuters
American Airlines sees bookings rebounding in summer
Goldman Sachs profit soars on global deals frenzy, trading boom
April 14, 2021Reuters
Goldman Sachs profit soars on global deals frenzy, trading boom
JPMorgan profits on capital markets in a cash-flush economy
April 14, 2021Reuters
JPMorgan profits on capital markets in a cash-flush economy
Wall Street opens flat as big banks kick off earnings season
April 14, 2021Reuters
Wall Street opens flat as big banks kick off earnings season
Kohl's strikes deal with activists, to name three new directors to its board
April 14, 2021CNBC
Kohl's strikes deal with activists, to name three new directors to its board
Bernie Madoff, mastermind of the nation's biggest investment fraud, dies at 82
April 14, 2021CNBC
Bernie Madoff, mastermind of the nation's biggest investment fraud, dies at 82
Energy firm plans hydrogen project that will use UK's largest electrolyzer
April 14, 2021CNBC
Energy firm plans hydrogen project that will use UK's largest electrolyzer
Goldman Sachs stock rises after record profit and revenue beat by wide margins
April 14, 2021MarketWatch
Goldman Sachs stock rises after record profit and revenue beat by wide margins
Hundreds of companies and executives sign statement opposing voting restrictions in two-page ad in New York Times
April 14, 2021MarketWatch
Hundreds of companies and executives sign statement opposing voting restrictions in two-page ad in New York Times
This new ETF gets you access to the backbone of the crypto world
April 14, 2021MarketWatch
This new ETF gets you access to the backbone of the crypto world
U.S. stocks edge higher as investors parse Goldman Sachs, JPMorgan earnings
April 14, 2021MarketWatch
U.S. stocks edge higher as investors parse Goldman Sachs, JPMorgan earnings
J.P. Morgan net profit soars fivefold to $14.3 billion and revenue tops expectations, but stock slips
April 14, 2021MarketWatch
J.P. Morgan net profit soars fivefold to $14.3 billion and revenue tops expectations, but stock slips
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
April 14, 2021MarketWatch
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
This robot-run fund with a history of predicting Tesla price moves has just made these stock picks
April 14, 2021MarketWatch
This robot-run fund with a history of predicting Tesla price moves has just made these stock picks